AtriCure (ATRC) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BTIG Trims PT on AtriCure (ATRC) to $19; Management 'Disconnect' Causes Concern
August 8, 2016 11:17 AM EDTBTIG cut its price target on Buy-rated AtriCure (NASDAQ: ATRC) from $34 down to $19 after the company reported Q2 results late last week.
Analyst Sean Lavin commented, ATRC reported a relatively in-line but messy quarter with the core business coming in soft while increased focus on nContact... More
Needham & Company Cuts Price Target on AtriCure (ATRC) to $20; Reiterates Buy
August 5, 2016 8:34 AM EDTNeedham & Company maintained a Buy rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $20.00 (from $23.00), following the company's 2Q earnings report. Revenue was reported at $39.7M, a slight beat to the consensus estimate of $39.8M. EPS was ($0.26), ahead of consensus of ($0.30). ATRC lowered its... More
AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray
August 5, 2016 8:27 AM EDTPiper Jaffray analyst Brooks West cut his price target on AtriCure Inc. (NASDAQ: ATRC) to $17.00 (from $22.00) following Q2 results, but maintained an Overweight rating saying guidance reset could be a positive clearing event.
West commented, "AtriCure reported 2Q16 revenues of $39.7M (+21.5% cc) vs. consensus of... More

